Address power of insurance companies in treating mental health
Mental health experts like Dr. Sledge (New Haven Register, Feb. 5,
2013) worry about the stigma of mental with good reason. Mental health care
practitioners routinely work with clients and families who have eschewed care
for years or even decades rather than risk being "labelled" with a
psychiatric diagnosis.
Most of these patients would not hesitate to seek medical
attention for a physical illness; nor an illness that is attributable to
lifestyle choices, and therefore preventable. Most mental illnesses are
not easily preventable; our clients don't choose to be ill, and their illnesses
ought not to be stigmatized.
Neither should our profession. Psychiatric care
practitioners are among the lowest paid care providers, along with
pediatricians and primary/preventive caregivers.
Across this country in the wake of Newtown and Virginia Tech
and Columbine has risen a chorus of acknowledgement that the populace in
under-served by our mental health care systems. Sadly, those voices are
not echoed by the corporations that set the reimbursement rates for most of the
mental health care delivery in this country and in our state.
Consider the devaluation of psychiatric care by one of
the nation's leading private insurance corporations, which controls a
significant share of the commercially insured market in Connecticut. Their
reimbursement rate for a widely practiced treatment, the 45-minute office visit
with a medicated patient, remained flat between 2007 and 2012. This is in
fact a yearly decrease when adjusted for inflation and cost of living
increases. That company took advantage of an updated national protocol
for coding healthcare that went into effect Jan. 1, 2013 to cut the 2007
rate for a 45-minute service by an additional 15 percent. Meanwhile, up-front
deductibles and patient co-payments, both of which are disincentives to seeking
care, have steadily increased.
Yet some treatment modalities have become more profitable.
Short visits, with minimal if any meaningful clinical interaction, where
prescriptions for psychiatric medications are provided, remain lucrative.
For those of us with DEA numbers, the economic signaling toward a
factory-based model of care is unmistakeable. Talk is cheap.
"Therapy" takes place down the hall by allied professionals, or across
town at a reduced hourly rate, and sometimes not at all.
"Coordination of care" among disparate practitioners at distant
locations who share a client's care with a prescriber who is medicating 5 to 8
clients per hour, sometimes more, is a far-fetched notion. Many of us who
engage in it know better. But the opportunity to double or quadruple
one's income by abiding a profit-driven care model is difficult to resist, even
among professionals whose original interest in mental health was to serve those
in need.
Insurers regulate the practice of medicine de facto.
They are neither legislative nor regulatory entities, yet we
have allowed them to act with that authority.
If, as we profess, particularly in the aftermath of a
crisis, this country values a competent mental health system whose interests
are aligned with those of the public it serves, we should demand from our
legislators and from the regulatory bodies they entrust to act on our behalf,
that the economic signals of the profit-makers truly align with the delivery of
efficacious care to the public.
John M Roy
North Haven
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home